EGFR and lung carcinoma: We found that patients with high CD151 levels had a higher rate of disease‐specific death from lung cancer than those with low CD151 levels (p = 0.045, Figure 1E), supporting our conclusion that CD151 overexpression is of prognostic value for lung cancer patients without EGFR mutations.